This is the authors' abstract. We don't add key points for this paper.
Solid lipid nanoparticles (SLN) are a colloidal carrier system for controlled drug delivery. The lipophilic model drugs tetracaine and etomidate were incorporated to study the maximum drug loading, entrapment efficacy, effect of drug incorporation on SLN size, zeta potential (charge) and long-term physical stability. Drug loads of up to 10% could be achieved whilst simultaneously maintaining a physically stable nanoparticle dispersion. Incorporation of drugs showed no or little effect on particle size and zeta potential compared to drug-free SLN. The optimized production parameters previously established for drug-free SLN dispersions can therefore be transferred to drug-loaded systems to facilitate product development.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
C. Schwarz (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: